Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2−), node negative breast cancer in the randomized TAILORx trial:...

por Beltran-Bless, Ana-Alicia, Ng, Terry L.
Publicado 2022

Explaining risks and benefits of loco-regional treatments to patients

por Beltran-Bless, Ana-Alicia, Kacerovsky-Strobl, Stephanie, Gnant, Michael
Publicado 2023

Lost in Transition? Thoughts on Retirement, Part 2. “Should I Stay or Should I Go Now?”

por Beltran‐Bless, Ana‐Alicia, Vandermeer, Brent, Paterson, Alexander, Gunstone, Ian, Kaizer, Leonard, Arnaout, Angel, Vandermeer, Lisa, Clemons, Mark
Publicado 2021

Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?

por Beltran-Bless, Ana-Alicia, Vandermeer, Lisa, Ibrahim, Mohammed F. K., Hutton, Brian, Shorr, Risa, Savard, Marie-France, Clemons, Mark
Publicado 2021

Regularly scheduled physical examinations and the detection of breast cancer recurrences

por Beltran-Bless, Ana-Alicia, Alshamsan, Bader, Alzahrani, Mashari Jemaan, Hilton, John, Baines, Kelly-Anne, Samuel, Vicky, Pond, Gregory R., Vandermeer, Lisa, Clemons, Mark, Larocque, Gail
Publicado 2023

The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer

por Surujballi, Julian, Shah, Hely, Hutton, Brian, Alzahrani, Mashari, Beltran-Bless, Ana-Alicia, Shorr, Risa, Larocque, Gail, McGee, Sharon, Cole, Katherine, Ibrahim, Mohammed F.K., Fernandes, Ricardo, Arnaout, Angel, Stober, Carol, Liu, Michelle, Sienkiewicz, Marta, Saunders, Deanna, Vandermeer, Lisa, Clemons, Mark
Publicado 2021